AngioDynamics Inc (ANGO)
5.82
+0.03
(+0.52%)
USD |
NASDAQ |
May 01, 10:12
AngioDynamics Cash from Investing (Quarterly): 29.40M for Feb. 29, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 29.40M |
| November 30, 2023 | -1.793M |
| August 31, 2023 | 98.44M |
| May 31, 2023 | -1.528M |
| February 28, 2023 | -2.146M |
| November 30, 2022 | -2.496M |
| August 31, 2022 | -3.576M |
| May 31, 2022 | -3.773M |
| February 28, 2022 | -2.593M |
| November 30, 2021 | -3.849M |
| August 31, 2021 | -9.092M |
| May 31, 2021 | -9.144M |
| February 28, 2021 | -1.382M |
| November 30, 2020 | -1.361M |
| August 31, 2020 | -1.824M |
| May 31, 2020 | -1.479M |
| February 29, 2020 | -11.74M |
| November 30, 2019 | -48.58M |
| August 31, 2019 | -1.541M |
| May 31, 2019 | 168.43M |
| February 28, 2019 | 0.463M |
| November 30, 2018 | -48.65M |
| August 31, 2018 | -37.68M |
| May 31, 2018 | -0.744M |
| February 28, 2018 | -1.69M |
| Date | Value |
|---|---|
| November 30, 2017 | -0.721M |
| August 31, 2017 | -0.501M |
| May 31, 2017 | -0.743M |
| February 28, 2017 | -0.412M |
| November 30, 2016 | -0.915M |
| August 31, 2016 | -0.481M |
| May 31, 2016 | -3.681M |
| February 29, 2016 | -2.745M |
| November 30, 2015 | -0.40M |
| August 31, 2015 | -0.743M |
| May 31, 2015 | -0.694M |
| February 28, 2015 | -4.269M |
| November 30, 2014 | -2.515M |
| August 31, 2014 | -5.258M |
| May 31, 2014 | -3.424M |
| February 28, 2014 | -1.817M |
| November 30, 2013 | -4.438M |
| August 31, 2013 | -6.769M |
| May 31, 2013 | -4.412M |
| February 28, 2013 | -11.39M |
| November 30, 2012 | -8.732M |
| August 31, 2012 | 2.293M |
| May 31, 2012 | -150.79M |
| February 29, 2012 | -16.70M |
| November 30, 2011 | -8.451M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-48.58M
Minimum
Nov 2019
168.43M
Maximum
May 2019
9.418M
Average
-1.985M
Median
Cash from Investing (Quarterly) Benchmarks
| Becton Dickinson & Co | -233.00M |
| Outset Medical Inc | 23.42M |
| Integer Holdings Corp | -168.20M |
| Perspective Therapeutics Inc | -0.089M |
| Xtant Medical Holdings Inc | -2.313M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.53M |
| Cash from Financing (Quarterly) | 0.694M |
| Free Cash Flow | -23.46M |
| Free Cash Flow Per Share (Quarterly) | -0.4072 |
| Free Cash Flow to Equity (Quarterly) | -16.38M |
| Free Cash Flow to Firm (Quarterly) | -16.38M |
| Free Cash Flow Yield | -10.08% |